A pilot study using neuropsychological testing from the Arimidex, Tamoxifen, Alone or in Combination (ATAC) trial showed that patients receiving hormone therapy performed lower on processing speed ...

Patients were randomly allocated to receive anastrozole 1 mg daily or placebo, in addition to their usual GH therapy, and were examined at 3-month intervals. Anastrozole treatment continued for 36 ...

Cognitive dysfunction has been considered as a morbid condition that may possibly result from aromatase inhibitor therapy, the standard treatment in postmenopausal, estrogen/progesterone receptor ...

Arimidex is an aromatase inhibitor ... in postmenopausal women with disease progression, following tamoxifen therapy. Casodex is an androgen-receptor inhibitor, indicated for use in combination ...

Early initiation of moderate-intensity aerobic exercise may prevent worsening musculoskeletal pain in postmenopausal women receiving aromatase inhibitor therapy for breast cancer, according to study ...